FDA on confusing drug names and the Second Circuits on rogue science
Five pharma litigation hot topics in three minutes
United States | Video | January 2021 | 03:46
Video Details
This week, Jan Dodd, a partner in Los Angeles whose practice focuses on advising pharmaceutical, medical device, and manufacturing companies on product liability lawsuits and risk mitigation, discusses:
- FDA guidance
- Drug pricing
- Daubert
- Securities class action
- Did you know?
© Norton Rose Fulbright LLP 2020